Unlocking Treatment Strategies for Anaplastic Thyroid Cancer

Joseph Scharpf, MD, FACS, Director of Head and Neck Endocrine Surgery at the Cleveland Clinic Head and Neck Institute, and Emrullah Yilmaz, MD, PhD, an oncologist at Cleveland Clinic Taussig Cancer Institute, specializing in head and neck cancers, join the Cancer Advances podcast to discuss their study that provides insights to treatment strategies and tumor characteristics of anaplastic thyroid cancer. Listen as Dr. Scharpf and Dr. Yilmaz discuss patients with BRAF mutations and Cleveland Clinic's collaborative approach for thyroid cancer care.